JEVTANA is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen
JEVTANA is supplied as a kit containing one single-use vial of JEVTANA (cabazitaxel) Injection (clear glass vial with a grey rubber closure, aluminum cap and light green plastic flip-off cap) and one vial of Diluent for JEVTANA (13% (w/w) ethanol in water for injection) in a clear glass vial with a grey rubber closure, gold-color aluminum cap and colorless plastic flip-off cap
JEVTANA requires two dilutions prior to administration
First diluted solution of JEVTANA should be used immediately (within 30 minutes)
Fully prepared JEVTANA infusion solution (in either 0.9% sodium chloride solution or 5% dextrose solution) should be used within 8 hours at ambient temperature (including the one-hour infusion), or for a total of 24 hours (including the one-hour infusion) under the refrigerated conditions
PVC equipment should not be used
Manufacturer # 00024582411
Brand Jevtana®
Manufacturer Sanofi Pasteur
Country of Origin Unknown
Application Antineoplastic Agent
Container Type Single-Dose Vial
Dosage Form Injection
Generic Drug Code 28762
Generic Drug Name Cabazitaxel
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag N
NDC Number 00024582411
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Strength 60 mg / 1.5 mL
Supplier_ID 3885243
Type Intravenous
UNSPSC Code 51111728
Volume 1.5 mL
